Published in Clin Pharmacol Ther on April 01, 1983
Urolithiasis and hepatotoxicity are linked to the anion transporter Sat1 in mice. J Clin Invest (2010) 1.38
Structure, dynamics and selectivity in the sulfotransferase family. Drug Metab Rev (2013) 0.87
Sulphate in pregnancy. Nutrients (2015) 0.83
Increased bioavailability of phenylephrine by co-administration of acetaminophen: results of four open-label, crossover pharmacokinetic trials in healthy volunteers. Eur J Clin Pharmacol (2014) 0.83
Sulphate and osteoarthritis: decrease of serum sulphate levels by an additional 3-h fast and a 3-h glucose tolerance test after an overnight fast. Ann Rheum Dis (2006) 0.82
Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol. Br J Clin Pharmacol (1987) 0.81
Reduced sulfate plasma concentrations in the BTBR T+tf/J mouse model of autism. Physiol Behav (2012) 0.78
Semi-mechanistic kidney model incorporating physiologically-relevant fluid reabsorption and transporter-mediated renal reabsorption: pharmacokinetics of γ-hydroxybutyric acid and L-lactate in rats. J Pharmacokinet Pharmacodyn (2015) 0.76
Extracellular Cl(-) regulates human SO4 (2-)/anion exchanger SLC26A1 by altering pH sensitivity of anion transport. Pflugers Arch (2016) 0.75
Sex-specific effects of serum sulfate level and SLC13A1 nonsense variants on DHEA homeostasis. Mol Genet Metab Rep (2017) 0.75
Influence of leisure activity on the incidence of Alzheimer's disease. Neurology (2001) 4.49
Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation. Mol Cell Biol (2001) 2.72
Reliability of measurements obtained with the Timed "Up & Go" test in people with Parkinson disease. Phys Ther (2001) 2.49
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang (2005) 2.47
Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology (1998) 2.38
Intraoperative 'no go' donor hepatectomies in living donor liver transplantation. Am J Transplant (2010) 2.33
Pharmacokinetics of theophylline in children with asthma. Pediatrics (1976) 2.31
Relationship between theophylline concentration in plasma and saliva of man. Clin Pharmacol Ther (1974) 2.26
Accuracy of family history data on Parkinson's disease. Neurology (2003) 2.15
Improved survival of the diabetic foot: the role of a specialized foot clinic. Q J Med (1986) 2.11
Pectoralis tendon avulsion in the skeletally immature. Am J Orthop (Belle Mead NJ) (1996) 2.02
Observations on the Occurrence, Distribution, and Seasonal Incidence of Blue-green Algal Viruses. Appl Microbiol (1967) 1.98
Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man. Clin Pharmacol Ther (1972) 1.90
The changing natural history of spinal muscular atrophy type 1. Neurology (2007) 1.87
Enhancement of glucuronide-conjugating capacity in a hyperbilirubinemic infant due to apparent enzyme induction by phenobarbital. N Engl J Med (1966) 1.83
Pharmacokinetics of salicylate elimination in man. J Pharm Sci (1965) 1.78
Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol (1998) 1.77
Gastrointestinal clearance of drugs with activated charcoal. N Engl J Med (1982) 1.73
Isolation and characterization of AS-1, a phycovirus infecting the blue-green algae, Anacystis nidulans and Synechococcus cedrorum. Virology (1972) 1.71
Effect of activated charcoal on aspirin absorption in man. Part I. Clin Pharmacol Ther (1972) 1.70
Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation (1999) 1.67
Salicylate accumulation kinetics in man. N Engl J Med (1972) 1.65
Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect. Clin Pharmacol Ther (1976) 1.63
Anonymous living liver donation: donor profiles and outcomes. Am J Transplant (2010) 1.60
Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology (1995) 1.56
Pharmacokinetics of acetaminophen in the human neonate: formation of acetaminophen glucuronide and sulfate in relation to plasma bilirubin concentration and D-glucaric acid excretion. Pediatrics (1975) 1.52
Kinetics of pharmacologic effects in man: the anticoagulant action of warfarin. Clin Pharmacol Ther (1969) 1.50
Anionic permeability of cortical neurones. Exp Brain Res (1969) 1.50
Effect of an anticholinergic agent on riboflavin absorption in man. J Pharm Sci (1972) 1.49
Action of baclofen on mammalian synaptic transmission. Neuroscience (1978) 1.48
Vacuum probe: new approach to the microbiological sampling of surfaces. Appl Microbiol (1969) 1.48
Additional sequence complexity in the muscle gene, unc-22, and its encoded protein, twitchin, of Caenorhabditis elegans. Genetics (1993) 1.47
An octopus-bioinspired solution to movement and manipulation for soft robots. Bioinspir Biomim (2011) 1.45
Potentiation of isoproterenol effect by ascorbic acid. Res Commun Chem Pathol Pharmacol (1976) 1.43
The ALSFRSr predicts survival time in an ALS clinic population. Neurology (2005) 1.42
Performance on clinical tests of balance in Parkinson's disease. Phys Ther (1998) 1.40
Xenotransplantation. Can J Surg (1999) 1.39
Human myosin VIIA responsible for the Usher 1B syndrome: a predicted membrane-associated motor protein expressed in developing sensory epithelia. Proc Natl Acad Sci U S A (1996) 1.38
Drug biotransformation interactions in man. 3. Acetaminophen and salicylamide. J Pharm Sci (1971) 1.35
Substance P and spinal neurones. Can J Physiol Pharmacol (1975) 1.34
Effect of phenobarbital on hyperbilirubinemia and glucuronide formation in newborns. Am J Dis Child (1970) 1.33
Reduction or prevention of aspirin-induced occult gastrointestinal blood loss in man. Clin Pharmacol Ther (1969) 1.33
Clinical tests of standing balance: performance of persons with multiple sclerosis. Arch Phys Med Rehabil (2000) 1.31
Evaluation of virological procedures to detect fetal human cytomegalovirus infection: avidity of IgG antibodies, virus detection in amniotic fluid and maternal serum. J Med Virol (1996) 1.30
A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B. Hepatology (2001) 1.29
Drug biotransformation interactions in man. I. Mutual inhibition in glucuronide formation of salicylic acid and salicylamide in man. J Pharm Sci (1968) 1.29
Drug biotransformation interactions in man VI: acetaminophen and ascorbic acid. J Pharm Sci (1976) 1.28
Pharmacokinetic analysis of the effect of theophylline on pulmonary function in asthmatic children. J Pediatr (1975) 1.25
Pharmacokinetics of salicylamide elimination in man. J Pharmacol Exp Ther (1967) 1.25
Extracellular K + activity and slow potential changes in spinal cord and medulla. Can J Physiol Pharmacol (1972) 1.20
Serum protein binding of drugs during and after pregnancy in humans. Clin Pharmacol Ther (1980) 1.20
Effect of activated charcoal on acetaminophen absorption. Pediatrics (1976) 1.17
Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group. Hepatology (1999) 1.17
Effect of plasma protein and tissue binding on the biologic half-life of drugs. Clin Pharmacol Ther (1978) 1.16
Kinetics of salicylate elimination by newborn infants of mothers who ingested aspirin before delivery. Pediatrics (1974) 1.16
Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection. J Exp Med (1992) 1.15
Pharmacokinetics of salicylate in man. Drug Metab Rev (1979) 1.13
Evaluation of methods for producing renal dysfunction in rats. J Pharm Sci (1981) 1.13
Allelic and ectopic interactions in recombination-defective yeast strains. Genetics (1991) 1.13
Rashba spin-splitting control at the surface of the topological insulator Bi2Se3. Phys Rev Lett (2011) 1.11
Protein binding of warfarin enantiomers in serum of humans and rats. J Pharmacokinet Biopharm (1977) 1.11
Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. J Clin Oncol (1994) 1.10
Aspirin, absorption rate and analgesic effect. Anesth Analg (1966) 1.10
Evaluation of "true" creatinine clearance in rats reveals extensive renal secretion. Pharm Res (1991) 1.10
Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD. Neurology (2003) 1.09
Pharmacokinetic analysis of potentiating effect of phenylbutazone on anticoagulant action of warfarin in man. J Pharm Sci (1970) 1.09
Pharmacokinetics of acetaminophen elimination by anephric patients. J Pharmacol Exp Ther (1976) 1.09
Gait consistency over a 7-day interval in people with Parkinson's disease. Arch Phys Med Rehabil (1999) 1.09
Management of upper limb dysfunction in children with cerebral palsy: a systematic review. Eur J Neurol (2001) 1.08
Surgical exposure and orthodontic alignment of an unerupted primary maxillary second molar impacted by an odontoma and a dentigerous cyst: a case report. Quintessence Int (1990) 1.07
Fetal acquisition and neonatal elimination of a large amount of salicylate. Study of a neonate whose mother regularly took therapeutic doses of aspirin during pregnancy. Clin Pharmacol Ther (1975) 1.07
Urine pH and salicylate therapy. JAMA (1971) 1.06
Frequency distribution of free warfarin and free phenytoin fraction values in serum of healthy human adults. Clin Pharmacol Ther (1977) 1.06
Lactate provocation of panic attacks. I. Clinical and behavioral findings. Arch Gen Psychiatry (1984) 1.06
Importance of assay specificity for plasma protein binding determinations. J Pharmacokinet Biopharm (1975) 1.05
Kinetics of pharmacologic effects. Clin Pharmacol Ther (1966) 1.05
Pharmacokinetics in renal disease. Am J Med (1977) 1.04
Pharmacokinetics of drug action. Annu Rev Pharmacol (1972) 1.04
Decreased body clearance of diflunisal in renal insufficiency--an alternative explanation. Br J Clin Pharmacol (1979) 1.04
Comparative pharmacokinetics of coumarin anticoagulants. IV. Application of a three-compartmental model to the analysis of the dose-dependent kinetics of bishydroxycoumarin elimination. J Pharm Sci (1968) 1.03
Overexpression of poly(A)-binding protein down-regulates the translation or the abundance of its own mRNA. FEBS Lett (1999) 1.03
Reviewing knee osteoarthritis--a biomechanical perspective. J Sci Med Sport (2004) 1.03
Acetaminophen kinetics in acutely poisoned patients. Clin Pharmacol Ther (1979) 1.03
The effect of the knee adduction moment on tibial cartilage volume and bone size in healthy women. Rheumatology (Oxford) (2003) 1.02
Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients. J Infect Dis (2000) 1.02
Influence of setting on unattended respiratory monitoring in the sleep apnoea/hypopnoea syndrome. Eur Respir J (2001) 1.01
Pharmacokinetics of warfarin enantiomers: a search for intrasubject correlations. Clin Pharmacol Ther (1978) 1.01
From front line to home front: a study of secondary traumatization. Fam Process (1992) 1.01
Letter: Effect of plasma protein binding on elimination of warfarin. J Pharm Sci (1974) 1.00
Kinetics of drug action in disease states. II. Effect of experimental renal dysfunction on phenobarbital concentrations in rats at onset of loss of righting reflect. J Pharmacol Exp Ther (1984) 1.00
A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients. Liver Transpl (2001) 0.99
Dentine dysplasia with sclerotic bone and skeletal anomalies inherited as an autosomal dominant trait. A new syndrome. Oral Surg Oral Med Oral Pathol (1977) 0.99
Self-reported sleepiness while driving as a risk factor for traffic accidents in patients with obstructive sleep apnoea syndrome and in non-apnoeic snorers. Respir Med (2000) 0.99
Induction of macrophage procoagulant activity by Bacteroides fragilis. Infect Immun (1989) 0.99
The nucleocapsid protein of murine hepatitis virus type 3 induces transcription of the novel fgl2 prothrombinase gene. J Biol Chem (1999) 0.99
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation. Blood (2000) 0.99
Effect of antacids on pH of urine. Clin Pharmacol Ther (1974) 0.98
Effect of polysorbate 80 and oleic acid on drug absorption from the rat intestine. J Pharm Sci (1970) 0.98
Decreased serum salicylate concentrations in children with rheumatic fever treated with antacid. N Engl J Med (1975) 0.98
Pharmacokinetics of the warfarin enantiomers in rats. J Pharmacokinet Biopharm (1974) 0.98